Toward eliminating HLA class i expression to generate universal cells from allogeneic donors

Hiroki Torikai, Andreas Reik, Frank Soldner, Edus H. Warren, Carrie Yuen, Yuanyue Zhou, Denise L. Crossland, Helen Huls, Nicholas Littman, Ziying Zhang, Scott S. Tykodi, Partow Kebriaei, Dean A. Lee, Jeffrey C. Miller, Edward J. Rebar, Michael C. Holmes, Rudolf Jaenisch, Richard E. Champlin, Philip D. Gregory, Laurence J.N. Cooper

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Long-term engraftment of allogeneic cells necessitates eluding immune-mediated rejection, which is currently achieved by matching for human leukocyte antigen (HLA) expression, immunosuppression, and/or delivery of donor-derived cells to sanctuary sites. Genetic engineering provides an alternative approach to avoid clearance of cells that are recognized as "non-self" by the recipient. To this end, we developed designer zinc finger nucleases and employed a "hit-and-run" approach to genetic editing for selective elimination of HLA expression. Electro-transfer of mRNA species coding for these engineered nucleases completely disrupted expression of HLA-A on human T cells, including CD19-specific T cells. The HLA-A neg T-cell pools can be enriched and evade lysis by HLA-restricted cytotoxic T-cell clones. Recognition by natural killer cells of cells that had lost HLA expression was circumvented by enforced expression of nonclassical HLA molecules. Furthermore, we demonstrate that zinc finger nucleases can eliminate HLA-A expression from embryonic stem cells, which broadens the applicability of this strategy beyond infusing HLA-disparate immune cells. These findings establish that clinically appealing cell types derived from donors with disparate HLA expression can be genetically edited to evade an immune response and provide a foundation whereby cells from a single donor can be administered to multiple recipients.

Original languageEnglish (US)
Pages (from-to)1341-1349
Number of pages9
JournalBlood
Volume122
Issue number8
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

HLA Antigens
T-cells
T-Lymphocytes
Zinc Fingers
Zinc
Genetic engineering
Genetic Engineering
Embryonic Stem Cells
Stem cells
Natural Killer Cells
Immunosuppression
Clone Cells
Messenger RNA
Molecules

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Torikai, H., Reik, A., Soldner, F., Warren, E. H., Yuen, C., Zhou, Y., ... Cooper, L. J. N. (2013). Toward eliminating HLA class i expression to generate universal cells from allogeneic donors. Blood, 122(8), 1341-1349. https://doi.org/10.1182/blood-2013-03-478255

Toward eliminating HLA class i expression to generate universal cells from allogeneic donors. / Torikai, Hiroki; Reik, Andreas; Soldner, Frank; Warren, Edus H.; Yuen, Carrie; Zhou, Yuanyue; Crossland, Denise L.; Huls, Helen; Littman, Nicholas; Zhang, Ziying; Tykodi, Scott S.; Kebriaei, Partow; Lee, Dean A.; Miller, Jeffrey C.; Rebar, Edward J.; Holmes, Michael C.; Jaenisch, Rudolf; Champlin, Richard E.; Gregory, Philip D.; Cooper, Laurence J.N.

In: Blood, Vol. 122, No. 8, 01.01.2013, p. 1341-1349.

Research output: Contribution to journalArticle

Torikai, H, Reik, A, Soldner, F, Warren, EH, Yuen, C, Zhou, Y, Crossland, DL, Huls, H, Littman, N, Zhang, Z, Tykodi, SS, Kebriaei, P, Lee, DA, Miller, JC, Rebar, EJ, Holmes, MC, Jaenisch, R, Champlin, RE, Gregory, PD & Cooper, LJN 2013, 'Toward eliminating HLA class i expression to generate universal cells from allogeneic donors', Blood, vol. 122, no. 8, pp. 1341-1349. https://doi.org/10.1182/blood-2013-03-478255
Torikai, Hiroki ; Reik, Andreas ; Soldner, Frank ; Warren, Edus H. ; Yuen, Carrie ; Zhou, Yuanyue ; Crossland, Denise L. ; Huls, Helen ; Littman, Nicholas ; Zhang, Ziying ; Tykodi, Scott S. ; Kebriaei, Partow ; Lee, Dean A. ; Miller, Jeffrey C. ; Rebar, Edward J. ; Holmes, Michael C. ; Jaenisch, Rudolf ; Champlin, Richard E. ; Gregory, Philip D. ; Cooper, Laurence J.N. / Toward eliminating HLA class i expression to generate universal cells from allogeneic donors. In: Blood. 2013 ; Vol. 122, No. 8. pp. 1341-1349.
@article{f30a05550d034a6c8f8e08028c22760a,
title = "Toward eliminating HLA class i expression to generate universal cells from allogeneic donors",
abstract = "Long-term engraftment of allogeneic cells necessitates eluding immune-mediated rejection, which is currently achieved by matching for human leukocyte antigen (HLA) expression, immunosuppression, and/or delivery of donor-derived cells to sanctuary sites. Genetic engineering provides an alternative approach to avoid clearance of cells that are recognized as {"}non-self{"} by the recipient. To this end, we developed designer zinc finger nucleases and employed a {"}hit-and-run{"} approach to genetic editing for selective elimination of HLA expression. Electro-transfer of mRNA species coding for these engineered nucleases completely disrupted expression of HLA-A on human T cells, including CD19-specific T cells. The HLA-A neg T-cell pools can be enriched and evade lysis by HLA-restricted cytotoxic T-cell clones. Recognition by natural killer cells of cells that had lost HLA expression was circumvented by enforced expression of nonclassical HLA molecules. Furthermore, we demonstrate that zinc finger nucleases can eliminate HLA-A expression from embryonic stem cells, which broadens the applicability of this strategy beyond infusing HLA-disparate immune cells. These findings establish that clinically appealing cell types derived from donors with disparate HLA expression can be genetically edited to evade an immune response and provide a foundation whereby cells from a single donor can be administered to multiple recipients.",
author = "Hiroki Torikai and Andreas Reik and Frank Soldner and Warren, {Edus H.} and Carrie Yuen and Yuanyue Zhou and Crossland, {Denise L.} and Helen Huls and Nicholas Littman and Ziying Zhang and Tykodi, {Scott S.} and Partow Kebriaei and Lee, {Dean A.} and Miller, {Jeffrey C.} and Rebar, {Edward J.} and Holmes, {Michael C.} and Rudolf Jaenisch and Champlin, {Richard E.} and Gregory, {Philip D.} and Cooper, {Laurence J.N.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1182/blood-2013-03-478255",
language = "English (US)",
volume = "122",
pages = "1341--1349",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - Toward eliminating HLA class i expression to generate universal cells from allogeneic donors

AU - Torikai, Hiroki

AU - Reik, Andreas

AU - Soldner, Frank

AU - Warren, Edus H.

AU - Yuen, Carrie

AU - Zhou, Yuanyue

AU - Crossland, Denise L.

AU - Huls, Helen

AU - Littman, Nicholas

AU - Zhang, Ziying

AU - Tykodi, Scott S.

AU - Kebriaei, Partow

AU - Lee, Dean A.

AU - Miller, Jeffrey C.

AU - Rebar, Edward J.

AU - Holmes, Michael C.

AU - Jaenisch, Rudolf

AU - Champlin, Richard E.

AU - Gregory, Philip D.

AU - Cooper, Laurence J.N.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Long-term engraftment of allogeneic cells necessitates eluding immune-mediated rejection, which is currently achieved by matching for human leukocyte antigen (HLA) expression, immunosuppression, and/or delivery of donor-derived cells to sanctuary sites. Genetic engineering provides an alternative approach to avoid clearance of cells that are recognized as "non-self" by the recipient. To this end, we developed designer zinc finger nucleases and employed a "hit-and-run" approach to genetic editing for selective elimination of HLA expression. Electro-transfer of mRNA species coding for these engineered nucleases completely disrupted expression of HLA-A on human T cells, including CD19-specific T cells. The HLA-A neg T-cell pools can be enriched and evade lysis by HLA-restricted cytotoxic T-cell clones. Recognition by natural killer cells of cells that had lost HLA expression was circumvented by enforced expression of nonclassical HLA molecules. Furthermore, we demonstrate that zinc finger nucleases can eliminate HLA-A expression from embryonic stem cells, which broadens the applicability of this strategy beyond infusing HLA-disparate immune cells. These findings establish that clinically appealing cell types derived from donors with disparate HLA expression can be genetically edited to evade an immune response and provide a foundation whereby cells from a single donor can be administered to multiple recipients.

AB - Long-term engraftment of allogeneic cells necessitates eluding immune-mediated rejection, which is currently achieved by matching for human leukocyte antigen (HLA) expression, immunosuppression, and/or delivery of donor-derived cells to sanctuary sites. Genetic engineering provides an alternative approach to avoid clearance of cells that are recognized as "non-self" by the recipient. To this end, we developed designer zinc finger nucleases and employed a "hit-and-run" approach to genetic editing for selective elimination of HLA expression. Electro-transfer of mRNA species coding for these engineered nucleases completely disrupted expression of HLA-A on human T cells, including CD19-specific T cells. The HLA-A neg T-cell pools can be enriched and evade lysis by HLA-restricted cytotoxic T-cell clones. Recognition by natural killer cells of cells that had lost HLA expression was circumvented by enforced expression of nonclassical HLA molecules. Furthermore, we demonstrate that zinc finger nucleases can eliminate HLA-A expression from embryonic stem cells, which broadens the applicability of this strategy beyond infusing HLA-disparate immune cells. These findings establish that clinically appealing cell types derived from donors with disparate HLA expression can be genetically edited to evade an immune response and provide a foundation whereby cells from a single donor can be administered to multiple recipients.

UR - http://www.scopus.com/inward/record.url?scp=84886849781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886849781&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-03-478255

DO - 10.1182/blood-2013-03-478255

M3 - Article

C2 - 23741009

AN - SCOPUS:84886849781

VL - 122

SP - 1341

EP - 1349

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -